- Home
- Automated
- List of product information
- TAMSULOSIN-TEVA PROLONGED RELEASE FILM-COATED TABLET 400MCG [SIN16191P]
TAMSULOSIN-TEVA PROLONGED RELEASE FILM-COATED TABLET 400MCG [SIN16191P]
Active ingredients: TAMSULOSIN-TEVA PROLONGED RELEASE FILM-COATED TABLET 400MCG
Last updated 26 October 2025
On this page
Product Info
TAMSULOSIN-TEVA PROLONGED RELEASE FILM-COATED TABLET 400MCG
[SIN16191P]
Product information
Active Ingredient and Strength | TAMSULOSIN EQV TAMSULOSIN HYDROCHLORIDE - 0.4 MG |
Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
Manufacturer and Country | TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY - HUNGARY |
Registration Number | SIN16191P |
Licence Holder | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | G04CA02 |
INDICATIONS
For the relief of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
DOSAGE AND ADMINISTRATION
One tablet daily.
The tablet must be swallowed whole and not be broken, crunched or chewed, as this compromises the prolonged release properties of the tablet for the active ingredient. Tamsulosin hydrochloride tablet can be taken on an empty stomach, or before, with or after food.
CONTRAINDICATIONS
Hypersensitivity to tamsulosin hydrochloride, including drug-induced angioedema or any other component of the product.
A history of orthostatic hypotension.
Severe hepatic impairment (Child-Pugh scores >9).
Severe renal impairment with creatinine clearance of less than 10mL/min.
Concurrent use of another α1-adrenoceptor inhibitor.